| This article has been cited by | | 1 | Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-a) inhibitors | | | Athanasios Tragiannidis,Ioannis Kyriakidis,Ilse Zündorf,Andreas H. Groll | | Mycoses.2017;60(4)222 | | [DOI] | | | 2 | Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors | | | Xin Li,Susanna KP Lau,Patrick CY Woo | | Experimental Biology and Medicine.2020;245(13)1104 | | [DOI] | | | 3 | Prognostic factors in 264 adults with invasiveScedosporiumspp. andLomentospora prolificansinfection reported in the literature and FungiScope® | | | Danila Seidel,Arne Meißner,Michaela Lackner,Ellen Piepenbrock,Jon Salmanton-García,Melanie Stecher,Sibylle Mellinghoff,Axel Hamprecht,Luisa Durán Graeff,Philipp Köhler,Matthew P. Cheng,Julie Denis,Isabelle Chedotal,Jagdish Chander,Diana Lynn Pakstis,Ibai Los-Arcos,Monica Slavin,Maria Teresa Montagna,Giuseppina Caggiano,Mihai Mares,Janina Trauth,Ute Aurbach,Maria J. G. T. Vehreschild,Jörg Janne Vehreschild,Rafael F. Duarte,Raoul Herbrecht,Hilmar Wisplinghoff,Oliver A. Cornely | | Critical Reviews in Microbiology.2019;45(1)1 | | [DOI] | | | 4 | Novel Presentation of Disseminated Scedosporium apiospermum in a Patient With Cystic Fibrosis | | | Ramona Bhatia,Shannon Galvin | | Infectious Diseases in Clinical Practice.2014;22(4)198 | | [DOI] | |
|
|
|
